A Multicenter Cohort Study on Maternal and Infant Microecology and New Targets for Pre-eclampsia Screening in China
Recruiting now
Conditions studied: Preeclampsia, Microbiome
In brief
major objective This multicenter, prospective cohort study aims at evaluating the predictive value of microbiome ,proteomics and serum markers in preeclampsia. secondary objective to evaluate the value of microbiome,proteomics and serum markers in assessing pregnancy outcome (complications during pregnancy and delivery, delivery) and neonatal prognosis.
Key facts
- Study ID
- NCT05445544
- Run by
- Zhujiang Hospital
- People needed
- 10000
- Starts
- 2022-10-19
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2023-02-08
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Aged >=18 years;
- Pregnancy woman;
- With a singleton pregnancy;
- Volunteer and receive regular antenatal examinations in the research centers;
- Volunteer to sign a written informed consent.
You may not qualify if…
- Concurrent with hypertension, diabetes, liver and kidney diseases, hematonosis and other serious diseases of pre-pregnancy women, including patients requiring long-term medication for primary diseases;
- With history of preeclampsia;
- Tumor patients concurrent with serious infection requiring long-term drug treatment;
- Pregnant women conceiving through in vitro fertilization;
- Multiple pregnancies;
- Patients with clear indications of medical pregnancy termination during early pregnancy;
- Any medical or non-medical conditions deemed inappropriate for study participation according to the investigator.
Where it is running
- Zhujiang Hospital of Southern Medical University — Guangzhou, Guangdong, China (enrolling)
- Zhujiang hospital — Guangzhou, Guangdong, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.